BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 38347590)

  • 1. Revealing role of epigenetic modifiers and DNA oxidation in cell-autonomous regulation of Cancer stem cells.
    Ferrer-Diaz AI; Sinha G; Petryna A; Gonzalez-Bermejo R; Kenfack Y; Adetayo O; Patel SA; Hooda-Nehra A; Rameshwar P
    Cell Commun Signal; 2024 Feb; 22(1):119. PubMed ID: 38347590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal Stem Cell-Secreted Extracellular Vesicles Instruct Stepwise Dedifferentiation of Breast Cancer Cells into Dormancy at the Bone Marrow Perivascular Region.
    Sandiford OA; Donnelly RJ; El-Far MH; Burgmeyer LM; Sinha G; Pamarthi SH; Sherman LS; Ferrer AI; DeVore DE; Patel SA; Naaldijk Y; Alonso S; Barak P; Bryan M; Ponzio NM; Narayanan R; Etchegaray JP; Kumar R; Rameshwar P
    Cancer Res; 2021 Mar; 81(6):1567-1582. PubMed ID: 33500249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomes from differentially activated macrophages influence dormancy or resurgence of breast cancer cells within bone marrow stroma.
    Walker ND; Elias M; Guiro K; Bhatia R; Greco SJ; Bryan M; Gergues M; Sandiford OA; Ponzio NM; Leibovich SJ; Rameshwar P
    Cell Death Dis; 2019 Jan; 10(2):59. PubMed ID: 30683851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic approach of Cancer stem cells (CSCs) in gastric adenocarcinoma; DNA methyltransferases enzymes in cancer targeted therapy.
    Norollahi SE; Mansour-Ghanaei F; Joukar F; Ghadarjani S; Mojtahedi K; Gharaei Nejad K; Hemmati H; Gharibpoor F; Khaksar R; Samadani AA
    Biomed Pharmacother; 2019 Jul; 115():108958. PubMed ID: 31075731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bone marrow niche in support of breast cancer dormancy.
    Walker ND; Patel J; Munoz JL; Hu M; Guiro K; Sinha G; Rameshwar P
    Cancer Lett; 2016 Sep; 380(1):263-71. PubMed ID: 26546045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone demethylase KDM6A coordinating with KMT2B regulates self-renewal and chemoresistance of non-small cell lung cancer stem cells.
    Chen Z; Qi Y; Shen J; Chen Z
    Transl Oncol; 2023 Nov; 37():101778. PubMed ID: 37683307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of Histone Methyltransferase, DOT1L, by Matrix Hyaluronan Promotes MicroRNA-10 Expression Leading to Tumor Cell Invasion and Chemoresistance in Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma.
    Bourguignon LY; Wong G; Shiina M
    J Biol Chem; 2016 May; 291(20):10571-85. PubMed ID: 27002147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-mediated changes in bone marrow microenvironment in breast cancer dormancy.
    Ferrer A; Roser CT; El-Far MH; Savanur VH; Eljarrah A; Gergues M; Kra JA; Etchegaray JP; Rameshwar P
    Cancer Lett; 2020 Sep; 488():9-17. PubMed ID: 32479768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory Role of Quiescence in the Biological Function of Cancer Stem Cells.
    Lee SH; Reed-Newman T; Anant S; Ramasamy TS
    Stem Cell Rev Rep; 2020 Dec; 16(6):1185-1207. PubMed ID: 32894403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of musashi 1 on breast cancer cells has implication to understand dormancy and survival in bone marrow.
    Nahas GR; Sherman LS; Sinha G; El Far MH; Petryna A; Munoz SM; Silverio KA; Shaker M; Neopane P; Mariotti V; Rameshwar P
    Aging (Albany NY); 2023 Mar; 15(9):3230-3248. PubMed ID: 36996499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of IL-20 Expression by Estradiol through KMT2B-Mediated Epigenetic Modification.
    Su CH; Lin IH; Tzeng TY; Hsieh WT; Hsu MT
    PLoS One; 2016; 11(11):e0166090. PubMed ID: 27806114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SET Domain-Containing Protein 4 Epigenetically Controls Breast Cancer Stem Cell Quiescence.
    Ye S; Ding YF; Jia WH; Liu XL; Feng JY; Zhu Q; Cai SL; Yang YS; Lu QY; Huang XT; Yang JS; Jia SN; Ding GP; Wang YH; Zhou JJ; Chen YD; Yang WJ
    Cancer Res; 2019 Sep; 79(18):4729-4743. PubMed ID: 31308046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging Role of Autophagy in Governing Cellular Dormancy, Metabolic Functions, and Therapeutic Responses of Cancer Stem Cells.
    Tiwari M; Srivastava P; Abbas S; Jegatheesan J; Ranjan A; Sharma S; Maurya VP; Saxena AK; Sharma LK
    Cells; 2024 Mar; 13(5):. PubMed ID: 38474411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GRWD1-WDR5-MLL2 Epigenetic Complex Mediates H3K4me3 Mark and Is Essential for Kaposi's Sarcoma-Associated Herpesvirus-Induced Cellular Transformation.
    Wei S; Lu S; Liang L; Wang X; Li W; Li T; Chen L; Ju E; Zhang X; Lai Z; Huang Y; Lu X; Gao SJ
    mBio; 2021 Dec; 12(6):e0343121. PubMed ID: 34933446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epigenetic/noncoding origin of tumor dormancy.
    Crea F; Nur Saidy NR; Collins CC; Wang Y
    Trends Mol Med; 2015 Apr; 21(4):206-11. PubMed ID: 25771096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic demethylation of sFRPs, with emphasis on sFRP4 activation, leading to Wnt signalling suppression and histone modifications in breast, prostate, and ovary cancer stem cells.
    Deshmukh A; Arfuso F; Newsholme P; Dharmarajan A
    Int J Biochem Cell Biol; 2019 Apr; 109():23-32. PubMed ID: 30710752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dormancy and cancer stem cells: An enigma for cancer therapeutic targeting.
    Talukdar S; Bhoopathi P; Emdad L; Das S; Sarkar D; Fisher PB
    Adv Cancer Res; 2019; 141():43-84. PubMed ID: 30691685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptomic and epigenetic analysis of breast cancer stem cells.
    Li G; Wang D; Ma W; An K; Liu Z; Wang X; Yang C; Du F; Han X; Chang S; Yu H; Zhang Z; Zhao Z; Zhang Y; Wang J; Sun Y
    Epigenomics; 2018 Jun; 10(6):765-783. PubMed ID: 29480027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WDR5 represents a therapeutically exploitable target for cancer stem cells in glioblastoma.
    Mitchell K; Sprowls SA; Arora S; Shakya S; Silver DJ; Goins CM; Wallace L; Roversi G; Schafer RE; Kay K; Miller TE; Lauko A; Bassett J; Kashyap A; D'Amato Kass J; Mulkearns-Hubert EE; Johnson S; Alvarado J; Rich JN; Holland EC; Paddison PJ; Patel AP; Stauffer SR; Hubert CG; Lathia JD
    Genes Dev; 2023 Feb; 37(3-4):86-102. PubMed ID: 36732025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.